Articles Referencing CORT

Wider-than-Expected Loss at Corcept - Analyst Blog

5/7/2013, 12:25 pm from Zacks.com in Investing, Business, Stocks

Corcept Therapeutics Inc. ( CORT ) posted a loss per share of 11 cents in the first quarter of 2013, wider than the Zacks Consensus Estimate of a loss of 10 cents. In the year-ago quarter,... Read >>

Corcept's Loss Narrows in 4Q - Analyst Blog

3/14/2013, 2:12 pm from Zacks.com in Investing, Business, Stocks

Corcept Therapeutics Inc. ( CORT ) posted a loss per share of 11 cents in the fourth quarter of 2012 which was narrower than the loss of 12 cents posted in the year-ago quarter Adjusted... Read >>

Corcept Provides 4Q & 2012 Outlook - Analyst Blog

2/15/2013, 5:05 pm from Zacks.com in Investing, Business, Stocks

Corcept Therapeutics Inc. ( CORT ) recently released preliminary results for the fourth quarter and full year 2012. Corcept expects fourth quarter revenues to come around $1.4 million, up... Read >>

Regeneron Wins FDA Approval for Eye Drug: 3 Companies Up For Approval

12/3/2011, 10:27 pm from Kapitall in Investing, Investing Ideas, Stocks, Technology

Written by Alexander Crawford. FDA decision data sourced from RTT News. On Tuesday the Food and Drug Administration approved Regeneron Pharmaceuticals’ ( REGN ) drug Eylea to treat a common... Read >>

The Top 20 Most Undervalued Healthcare Stocks By Target Price

1/14/2011, 3:44 pm from Kapitall in Investing, Investing Ideas, Stocks

Compiled by Luis Gonzalez: The following is a list of the most undervalued healthcare stocks, when comparing the current price against the average analyst target price (used as a proxy for fair... Read >>